The National Clinical Programme for Diabetes invite you to a webinar to highlight and launch a number of updated & newly published documents on Wednesday 28th February 2024

Dear Colleagues

The National Clinical Programme for Diabetes invite you to a webinar to highlight and launch a number of updated and newly published documents on Wednesday 28th February 2024 11.00-13.0.

Documents include:
– Diabetes in Pregnancy: A Model of Care for Ireland (2024)
– Sick Day Advice Leaflets
– Insulin Titration guidelines for Nurses & Midwives working with people with Diabetes
– National Diabetes Prevention Programme Report
– DISCOVER Type 2 Diabetes Report
– Language Matters Document (in collaboration with Diabetes Ireland)
– Survey Report: Transition of care of Adolescents/Young Adults with Type 1 Diabetes Mellitus from paediatric to adult outpatient services

Speakers:
 Minister for Health
 National Clinical Advisor Chronic Disease Dr. Sarah O’Brien
 Prof Fidelma Dunne (President of IES)
 Prof Mary Higgins
 Clinical Lead Prof O’Keeffe
 Prof Sean Dinneen
 Pw Diabetes
 AMP Ms. Ciara Coveney
 Nursing & HSCP NCP Diabetes leads
 Self-Management Education team

Please find the registration link below: 

Webinar registration invite Diabetes NCP 28022024

January edition of Diabetes Clinical Trial Network monthly newsletter

Dear IES Members and Affiliates

Please find the the January edition of Diabetes Clinical Trial Network monthly newsletter, which is packed with exciting updates, upcoming grant and funding opportunities. This newsletter is your key to staying informed and engaged with the Diabetes Collaborative Clinical Trial Network HRB DC-CTN • An all island collaborative network (diabetestrialsctn.ie).

DCTN January 2024 Newsletter

Two senior appointments announced for Institute for Clinical Trials   

Professor Fidelma Dunne appointed Interim Director and

John Kilmartin as Adjunct Professor

Photo Martina Regan

Tuesday January 30, 2024: World-leading research academic Professor Fidelma Dunne has been appointed Interim Director of the Institute for Clinical Trials at University of Galway.

Professor Dunne has an extensive background in clinical trial management and is ranked number 1 in Ireland and number 6 in the world for her research into gestational diabetes.

The University has also announced John Kilmartin, former Vice-President of Regulatory Affairs at Medtronic and an independent medtech regulatory expert, joins the Institute for Clinical Trials as Adjunct Professor.

Mr Kilmartin has more than 30 years’ experience in the medtech industry, with a particular focus on the emerging regulatory and clinical frameworks in Europe.

Professor Martin O’Donnell, Dean of the College of Medicine, Nursing and Health Sciences and Consultant Geriatrician at Saolta University Health Care Group, said: “We are honoured to have both Professor Fidelma Dunne and Mr John Kilmartin join the Institute for Clinical Trials. Their combined expertise in clinical trials, medical research and regulatory affairs will significantly contribute to our mission of advancing impactful clinical research. They will help to advance our clinical research goals and will make meaningful contributions to healthcare outcomes.”

Professor Dunne said: “Clinical trials in new medicines and devices are vital to improving the health of people living in Ireland and worldwide. Improving health also has economic and societal benefits. Engaging in clinical trials allows patients in Ireland to receive new medicines and devices early. We have a track record of designing and delivering impactful clinical trials at University of Galway and I am delighted to lead the Institute for Clinical Trials which will have a pivotal role in further enhancing the clinical research landscape in Ireland.”

Mr Kilmartin said: “The medtech industry is of huge importance to Ireland and Europe for the benefit of our patients, health systems and society. I believe that the Institute for Clinical Trials at University of Galway can play a key role in helping to support innovation in medtech by strategically targeting barriers within the Irish ecosystem. It aims to strengthen and further promote growth in the medtech sector, expand treatment options for patients and ultimately contribute to the advancement of healthcare on a broader scale.”

Bios

Professor Fidelma Dunne is the immediate past President of the International Association Diabetes in Pregnancy Study Groups and President of the Irish Endocrine Society (2021-2024). Professor Dunne has demonstrated an unwavering commitment to advancing research and improving outcomes in the critical area of diabetes and pregnancy.

Her research interests, focused on diabetes and pregnancy, have resulted in an impressive portfolio of over 240 peer-reviewed publications, 12,000 citations, and significant grant funding.

Professor Dunne was honoured with the Jorgen Pedersen award in 2021 for her exceptional work in Diabetes in Pregnancy. She is the Principal Investigator of the EMERGE randomised controlled trial, funded by the Health Research Board, with ground-breaking results published in the Journal of American Medical Association (JAMA) in October 2023 which showed that the drug metformin provided a safe and effective way to treat gestational diabetes.

John Kilmartin has a wealth of experience and knowledge in the medtech industry, having led global regulatory teams in the development and implementation of clinical and regulatory strategies for various medical devices and drug/device combination products.

He is actively involved with various medtech industry associations, including MedTech Europe and the Irish MedTech Association (IMA), where he served as the Chair of the IMA Regulatory Steering Committee for a number of years.

Mr Kilmartin has a strong focus on the evolving regulatory and clinical frameworks around the world, having collaborated with regulatory agencies such as FDA, European Notified Bodies, Competent authorities and other international regulators.

Mr Kilmartin’s areas of interest and focus include the development of the next generation of Regulatory and Clinical Affairs professionals, creating co-operative links between third-level institutions, the medtech industry, regulatory authorities, and government agencies to ensure that the medtech ecosystem continues to thrive in Ireland and in Europe.

Original article: University of Galway – College of Medicine, Nursing and Health Sciences on LinkedIn: NEWS: Two senior appointments announced for the Institute for Clinical… | 22 comments

Annual Irish Endocrine Society Study Day – 26th January 2024 programme and registration

Dear Colleagues

A very happy new year 2024 to you all!

Please find the 29th Irish Endocrine Society Annual Study Day programme and registration, which will take place on 26th January 2024 Friday at the Royal College of Physicians of Ireland, 6 Kildare Street, Dublin 2.  We have a fantastic line up of speakers, who are experts in areas of Diabetes and Endocrinology for the day. We look forward to seeing you all at the Study Day. 

The Study Day is free of charge for IES members who have paid your membership fees, and the paid up members will receive a discount code from the IES emailing list soon so that no fees incurred as you register for the Study Day.  The fee for non IES members is €120.

IES 2024 study day programme

Summary – Irish Endocrine Society Annual Study Day 2024 (cvent.com)

Joint Irish-UK Endocrine Meeting 2024 Call for Suggestions!

Irish Endocrine Society

 

 

Joint Irish-UK Endocrine Meeting 2024

 

47th Irish Endocrine Society Annual Meeting Programme – Updated!

Dear Colleagues

  • Please find the link below for the updated programme for the upcoming 47th IES Annual Meeting in Rosses Point, Sligo on 24th and 25th November 2023.
  • To Authors of oral and poster presentations, please check the updated programme carefully for the dates and times of your presentations.
  • For poster presentations, the presentation format is A0 Portrait. Other formats of poster presentations will not accepted due to space limitations at the conference venue.
  • As per instructions from the conference venue, posters presented on Friday 24th November 2023, are to be removed by 6:00 pm Friday. Posters presented on Saturday 25th November 2023, should be in place by 9:00 am Saturday and are to be removed by 11:00 am Saturday.
  • We have an exciting programme of lectures with invited speakers and scientific sessions with oral and poster presentations. We look forward to seeing you all in Sligo.

IES 2023 updated programme 21st Nov 2023

47th Irish Endocrine Society Annual Meeting Programme

Dear Colleagues

  • Please find the link below for the provisional programme for the upcoming 47th IES Annual Meeting in Rosses Point, Sligo on 24th and 25th November 2023.
  • For those of you who have submitted abstracts, please check the Annual Meeting Programme whether your abstract has been accepted or not.
  • If your abstract is accepted, please carefully check the type, date and time of your presentation in the programme.
  • Due to space limitations at the conference venue, 80 posters will be formally presented while other accepted abstracts will be published through the Irish Journal of Medical Science.
  • Senior authors: please ensure those presenting on your behalf are aware they have an oral or poster presentation.
  • We look forwarding to meeting you all at the Annual Meeting in Rosses Point.

IES 2023 updated programme 21st Nov 2023

LINK TO REGISTRATION

29th Annual Study Day – 26th January 2024

Dear Colleagues

We are delighted to announce that the 29th Irish Endocrine Society Annual Study Day will take place on 26th January 2024 Friday at the Royal College of Physicians of Ireland, 6 Kildare Street, Dublin 2.  We have a fantastic line up of speakers, who are experts in areas of Diabetes and Endocrinology for the day. A day not to be missed! Details on the full programme and registration will follow.

Accommodation for 47th Annual Meeting of Irish Endocrine Society Sligo 24/25 November 2023

Dear colleagues

Dr. Siobhan Bacon, who is the Local Organiser of 47th Annual Meeting, has asked to circulate the important information below regarding accommodation.

The IES2023 Annual Meeting is being held in the Radisson Hotel in Sligo on 24th and 25th of November 2023. 

The hotel is near Rosses Point approx. 4 km from the train station/town centre.

There are a number of hotel rooms being held at a special conference rate for the IES (175 euro for single B&B and 187 euro for double B&B). This rate will exist until the 2nd of November when rooms will be released to the general public.

Please contact (071) 914 0008, choose Option 1 and advise that you are attending the IES Meeting.

We hope to see you all at the upcoming IES2023 47th Annual Meeting. Registration for the meeting will open in the coming weeks. https://www.eventbrite.ie/e/47th-annual-meeting-of-irish-endocrine-society-registration-740270367597?aff=oddtdtcreator